tiprankstipranks
Nyxoah Launches Genio System in England for OSA
Company Announcements

Nyxoah Launches Genio System in England for OSA

Nyxoah (NYXH) has released an update.

Pick the best stocks and maximize your portfolio:

Nyxoah has launched its Genio system in England, marking a significant milestone in providing innovative treatment for Obstructive Sleep Apnea (OSA). The first successful implants were conducted at University College London Hospitals, underlining the system’s potential to address unmet needs in OSA therapy. With NHS coverage, Nyxoah aims to expand its collaboration with leading hospitals and enhance access to this groundbreaking therapy.

For further insights into NYXH stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyNyxoah announces commercial launch of Genio system in England
TipRanks Auto-Generated NewsdeskNyxoah Updates Share Capital and Voting Rights
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App